Advancing Science Together for a Better Tomorrow
At Waters, our purpose has always been centered on enhancing human health and well-being. Today, that purpose is more important than ever.
From the onset of the pandemic, Waters has partnered with organizations around the world to bring our resources and scientific capabilities, as well as those of our partners, to the forefront of the global fight against COVID-19. Led by our Innovation Response Team, Waters has been bringing together researchers with diverse scientific backgrounds and perspectives to help accelerate the pace of innovation of new diagnostics, therapies and vaccines.
While many challenges remain, our initial success in these efforts tells us that the scientific community is stronger and more powerful when it works together. As we continue to collaborate on finding solutions to the current COVID-19 pandemic, the element of partnership – the sharing of fresh ideas, collaborative problem solving, and diverse approaches, has emerged as a critical aspect in solving the complex challenges of the future.
With that collaborative spirit in mind, Waters recently opened Immerse Cambridge, an innovation and research lab in the heart of Kendall Square, located in Cambridge, MA, USA. The area is a hotbed for global innovation and is often referred to as “the most innovative square mile on the planet”. Immerse Cambridge is a strategic new addition to the neighborhood offering researchers across industries, a collaborative space where they can engage with Waters’ scientists in accelerating the next generation of scientific advancements for a better tomorrow.
On November 18th, 2020, Waters will host a virtual COVID Innovation Symposium live from Immerse Cambridge. Waters’ experts will be joined by our collaborators from around the globe to share information on vaccine development, current and future research challenges, and will discuss the role of mass spectrometry in helping defeat COVID-19.
Waters’ President and CEO, Udit Batra, will kick-off the symposium by hosting a panel discussion entitled “Contain the strain: Advancing an innovation ecosystem for infectious disease preparedness”. Udit will be joined by scientific leaders to discuss strategies for investment, innovation and preparedness to combat and cope with infectious diseases in a post-pandemic society. Panelists include:
- Sarah Fortune, MD, Chair and John LaPorte Given Professor Department of Immunology and Infectious Diseases | Harvard T.H. Chan School of Public Health
- David Sun Kong, Ph.D. Director, Community Biotechnology Initiative at MIT Media Lab
- John Maraganore CEO, Alnylam Pharmaceuticals
Click here to join our upcoming symposium and hear directly from industry leaders and fellow scientists on how working together has played a critical role in advancing COVID research.